Can see why the investment banking CEO jumped ship a while ago.
Lesson here for me was this went below my purchase price and I did nothing about it.
Market is telling us that PAB will spend the money its got now with no benefit to shareholders.
Much like the entire history of the company?
Now we see if the new CEO gets his 350 odd k a year for free or has a go at some of the hard stuff.
Ann: Manufacturing Update - Clinical Trial Remains on Hold, page-68
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.229M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $3.117K | 1.013M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 44343144 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 10764841 | 13 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| PAB (ASX) Chart |